AlphaCore Capital LLC purchased a new stake in Genpact Limited (NYSE:G – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,004 shares of the business services provider’s stock, valued at approximately $132,000.
Other institutional investors have also modified their holdings of the company. CWM LLC boosted its holdings in shares of Genpact by 85.5% in the 1st quarter. CWM LLC now owns 2,514 shares of the business services provider’s stock valued at $127,000 after buying an additional 1,159 shares in the last quarter. IFP Advisors Inc lifted its position in Genpact by 483.0% in the first quarter. IFP Advisors Inc now owns 2,612 shares of the business services provider’s stock valued at $132,000 after acquiring an additional 2,164 shares during the last quarter. Choreo LLC grew its holdings in shares of Genpact by 42.7% during the first quarter. Choreo LLC now owns 7,695 shares of the business services provider’s stock worth $388,000 after purchasing an additional 2,303 shares during the last quarter. Avantax Advisory Services Inc. increased its position in shares of Genpact by 72.7% during the first quarter. Avantax Advisory Services Inc. now owns 33,367 shares of the business services provider’s stock worth $1,681,000 after purchasing an additional 14,042 shares in the last quarter. Finally, Cetera Investment Advisers increased its position in shares of Genpact by 288.3% during the first quarter. Cetera Investment Advisers now owns 51,526 shares of the business services provider’s stock worth $2,596,000 after purchasing an additional 38,257 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Analysts Set New Price Targets
A number of analysts recently issued reports on G shares. JPMorgan Chase & Co. decreased their target price on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research report on Wednesday, August 20th. Needham & Company LLC boosted their price objective on Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research note on Friday, August 8th. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Finally, Citigroup upgraded shares of Genpact to a “hold” rating in a research note on Thursday, October 23rd. Three research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Genpact has an average rating of “Hold” and a consensus price target of $51.13.
Insiders Place Their Bets
In other news, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction that occurred on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. This represents a 15.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Sameer Dewan sold 26,531 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $44.70, for a total value of $1,185,935.70. Following the completion of the sale, the senior vice president directly owned 62,617 shares of the company’s stock, valued at $2,798,979.90. This represents a 29.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 161,183 shares of company stock worth $6,970,760. Company insiders own 2.80% of the company’s stock.
Genpact Stock Up 1.3%
Shares of Genpact stock opened at $44.64 on Wednesday. The company has a market cap of $7.70 billion, a P/E ratio of 14.40, a PEG ratio of 1.41 and a beta of 0.85. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51. Genpact Limited has a one year low of $37.49 and a one year high of $56.76. The firm has a fifty day moving average of $41.28 and a two-hundred day moving average of $42.99.
Genpact (NYSE:G – Get Free Report) last issued its earnings results on Thursday, November 6th. The business services provider reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The business had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the firm earned $0.85 earnings per share. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. On average, analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 annualized dividend and a yield of 1.5%. Genpact’s payout ratio is presently 21.94%.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- Upcoming IPO Stock Lockup Period, Explained
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- Energy and Oil Stocks Explained
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
- How to Profit From Growth Investing
- Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
